BackHemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock Other Liabilities

Track Hemab Therapeutics Holdings Common Stock's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Hemab Therapeutics Holdings Common Stock Other Liabilities History

Loading

Hemab Therapeutics Holdings Common Stock vs. peers: Other Liabilities Comparison

Loading

Hemab Therapeutics Holdings Common Stock Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

As of the most recent data (March 2026), COAG shows a other liabilities of $0. Scroll down for historical charts and peer comparison views.

Tracking COAG's other liabilities over time shows whether Hemab Therapeutics Holdings Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $0 Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Hemab Therapeutics Holdings Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.

Hemab Therapeutics Holdings Common Stock's other liabilities is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.